Treatment for glioblastoma (GBM)
Intended for US audiences only.

I didn't think I'd be alive today. Now here I am with Optune, still enjoying life."
Marcia, an Optune user

See her story ►

In people with newly diagnosed glioblastoma

Proven to extend survival and maintain quality of life*

A large clinical study showed that adding Optune to chemotherapy provided the greatest opportunity to live longer compared to chemotherapy alone at 5 years.

Optune® Better Survival at 5-years Optune® Better Survival at 5-years

In a 5-year follow-up, people on Optune plus chemotherapy lived longer across all groups analyzed regardless of well-being, age, gender, and how much of the tumor was removed.


People in the study were also able to maintain their mental, emotional, and physical well-being longer than those on chemotherapy alone.*

People adding Optune to chemotherapy in the study were also able to maintain their quality of life (mental, emotional, and physical health)* longer than those on chemotherapy alone.

Quality of life (mental, emotional, and physical health)
Optune® 2-year survival rate plus chemo

Nearly half of people using Optune + chemotherapy were alive at 2 years compared with 31% of people on chemotherapy alone.

In a large clinical study, people on Optune + chemotherapy lived longer than people on chemotherapy alone.

OVERALL SURVIVAL

Overall survival of people on Optune® + chemotherapy was 4.9 months longer than that of people on chemotherapy alone

In the same study, Optune + chemotherapy delayed tumor growth longer than chemotherapy alone.

PROGRESSION-FREE SURVIVAL

Progression-free survival of people on Optune® + chemotherapy was 3.2 months longer than that of people on chemotherapy alone


Optune treats where your glioblastoma tumor is located
without increasing chemotherapy-related side effects.

Optune® is effective against glioblastoma (GBM) when combined with chemotherapy, treats where the tumor is, and is wearable and portable Optune® is effective against glioblastoma (GBM) when combined with chemotherapy, treats where the tumor is, and is wearable and portable

Find an Optune doctor

By ZIP code

Hear from Optune users and caregivers

Get a firsthand view

*Quality of life was measured for up to 12 months.

Temozolomide, also known as Temodar®.

Next: Recurrent GBM >

US-OPT-02411

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.